Cargando…
Adherence to daily, oral TDF/FTC PrEP during periconception among HIV-exposed South African women
BACKGROUND: Daily, oral tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) as pre-exposure prophylaxis (PrEP) reduces HIV acquisition for African women. Adherence is key to efficacy and patterns of adherence can be highly variable in real-world settings. Using group-based trajectory modeling (GBT...
Autores principales: | Hurwitz, Kathleen E., Isehunwa, Oluwaseyi O., Hendrickson, Kayla R., Jaggernath, Manjeetha, Kriel, Yolandie, Smith, Patricia M., Mathenjwa, Mxolisi, Bennett, Kara, Psaros, Christina, Baeten, Jared M., Bangsberg, David R., Haberer, Jessica E., Smit, Jennifer A., Matthews, Lynn T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582627/ https://www.ncbi.nlm.nih.gov/pubmed/37860779 http://dx.doi.org/10.3389/frph.2023.1263422 |
Ejemplares similares
-
Influences on PrEP Uptake and Adherence Among South African Women During Periconception and Pregnancy: A Qualitative Analysis
por: Wyatt, Monique A., et al.
Publicado: (2022) -
Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa
por: Matthews, Lynn T, et al.
Publicado: (2019) -
How safe is TDF/FTC as PrEP? A systematic review and
meta-analysis of the risk of adverse events in 13 randomised trials of PrEP
por: Pilkington, Victoria, et al.
Publicado: (2018) -
Switching Tenofovir/Emtricitabine/Efavirenz (TDF/FTC/EFV) to TDF/FTC/Rilpivirine vs Continuing TDF/FTC/EFV in HIV-Infected Patients With Virological Suppression: A Randomized Controlled Trial
por: Wiriyatanakorn, Sirichai, et al.
Publicado: (2019) -
995. Safety and Efficacy of F/TAF and F/TDF for PrEP in DISCOVER Participants Taking F/TDF for PrEP at Baseline
por: Campbell, Thomas, et al.
Publicado: (2020)